secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001213900-25-125433
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics files prospectus supplement for up to $1.77M ATM offering
-------------------------------------------------------------------------------

- Already sold $10,005,300 in shares under the existing ATM agreement since March 2024.
- New tranche of up to $1,770,028 of common stock through H.C. Wainwright as sales agent.
- Commission of 3.0% of gross proceeds payable to Wainwright for its services.
- Offer made under existing effective S-3 registration statement filed March 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390025125433/0001213900-25-125433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390025125433/ea0270908-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-125433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer